UK markets close in 7 hours 13 minutes

AXIM Biotechnologies, Inc. (AXIM)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.0109+0.0023 (+26.74%)
At close: 11:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.89M
Enterprise value 9.46M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.85
Price/book (mrq)N/A
Enterprise value/revenue 111.17
Enterprise value/EBITDA -1.27

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-69.70%
S&P500 52-week change 322.55%
52-week high 30.0400
52-week low 30.0050
50-day moving average 30.0102
200-day moving average 30.0163

Share statistics

Avg vol (3-month) 3319.99k
Avg vol (10-day) 3189.88k
Shares outstanding 5291.46M
Implied shares outstanding 6291.46M
Float 8217.66M
% held by insiders 125.58%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-763.25%

Management effectiveness

Return on assets (ttm)-38.30%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)85.1k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)616.20%
Gross profit (ttm)N/A
EBITDA -2.02M
Net income avi to common (ttm)-5.59M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)96.71k
Total cash per share (mrq)0
Total debt (mrq)6.67M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.02
Book value per share (mrq)-0.03

Cash flow statement

Operating cash flow (ttm)-1.96M
Levered free cash flow (ttm)-1.78M